close
globe icon Global

成为细胞治疗的游戏规则改变者

我们在嵌合抗原受体 T 细胞治疗 (CAR T) 方面处于领先地位。您也可以。这种新兴免疫疗法对患者自身的 CD4+ 和 CD8+ T 细胞进行重新编码,以识别和攻击癌症。现在,我们正在通过一些临床试验探索更多的可能性。随着公司规模的不断扩大,我们正在寻找注重质量、充满激情的员工来帮助公司进一步深入发展。现在,展现您对创新的热爱和对在这个激动人心的领域产生影响的渴望吧!

Learn More

BMS

New State-of-the-Art Facility

Construction is underway for a new cell therapy manufacturing facility in Devens, MA. This is a part of Bristol Myers Squibb’s significant investment to support clinical and commercial manufacturing of transformative cell therapies for patients with aggressive hematological cancers. The Devens site will be equipped to enable quick ramp up of capacity for clinical and commercial cell therapy products. Manufacturing cell therapies is both operationally and technically complex because they are manufactured uniquely for each individual patient, and it is critical for companies to develop a reliable, quality supply and rapid turnaround time.

View Cellular Therapy Jobs in Devens

最新职位

从制造经理到首席科学家,现在就探索如何在我们的细胞治疗团队中找到您独特的位置。

查看细胞治疗工作

精诚合作,开拓创新

随着我们在细胞治疗领域的不断拓展,聆听我们团队对于如何帮助患者这一重大使命做出贡献的独特视角 。